DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+12.06%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$1.98B
AUM Growth
+$1.98B
(+0.88%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-9.04%
Top 10 Holdings %
Top 10 Hldgs %
29.8%
Holding
137
New
25
Increased
17
Reduced
34
Closed
28
Top Buys
| 1 |
THOR
THORATEC CORPORATION
THOR
|
$33.2M |
| 2 |
Viatris
VTRS
|
$29.7M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$28.9M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$25.7M |
| 5 |
Traws Pharma
TRAW
|
$25.6M |
Top Sells
Sector Composition
| 1 | Healthcare | 56.8% |
| 2 | Technology | 1.47% |
| 3 | Financials | 1.14% |
| 4 | Consumer Discretionary | 0% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
1
DELISTED
NxStage Medical Inc.
NXTM
| $66.2M | 3.08% | 5,027,164 +1,117,250 | +29% | +$14.7M |
|
|
ARRY
2
DELISTED
Array Biopharma Inc
ARRY
| $65.8M | 3.06% | 10,585,406 -300,000 | -3% | -$1.87M |
|
3
Pfizer
PFE
$141B
| $51.8M | 2.41% | 1,805,000 -50,000 | -3% | -$1.44M |
|
4
AstraZeneca
AZN
$248B
| $48.2M | 2.24% | 928,000 | – | – |
|
|
AUXL
5
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $45.3M | 2.11% | 2,488,328 -2,362,316 | -49% | -$43M |
|
6
AbbVie
ABBV
$372B
| $45M | 2.09% | 1,005,000 +388,000 | +63% | +$17.4M |
|
|
KERX
7
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $38.8M | 1.81% | 3,849,296 -2,015,316 | -34% | -$20.3M |
|
|
INFI
8
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $37.9M | 1.76% | 2,171,744 -183,219 | -8% | -$3.19M |
|
|
CBST
9
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $35.2M | 1.64% | 554,000 -141,000 | -20% | -$8.96M |
|
|
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
| $35.1M | 1.63% | 8,653,119 -746,881 | -8% | -$3.03M |
|
11
Teva Pharmaceuticals
TEVA
$21.1B
| $33.7M | 1.57% | 892,759 -350,000 | -28% | -$13.2M |
|
|
THOR
12
DELISTED
THORATEC CORPORATION
THOR
| $33.2M | 1.55% | +891,000 | New | +$33.2M |
|
13
Tenet Healthcare
THC
$16.3B
| $32.5M | 1.51% | 788,000 +379,880 | +93% | +$15.6M |
|
|
FRX
14
DELISTED
FOREST LABORATORIES INC
FRX
| $31.9M | 1.48% | 745,000 -200,000 | -21% | -$8.56M |
|
|
DYAX
15
DELISTED
DYAX CORPORATION
DYAX
| $30.4M | 1.41% | 4,432,625 +3,752,759 | +552% | +$25.7M |
|
|
16
Viatris
VTRS
$12.3B
| $29.7M | 1.38% | +778,000 | New | +$29.7M |
|
17
Community Health Systems
CYH
$387M
| $29.5M | 1.37% | 711,738 +75,614 | +12% | +$3.14M |
|
|
AIRM
18
DELISTED
Air Methods Corp
AIRM
| $29M | 1.35% | 680,561 -188,464 | -22% | -$8.02M |
|
|
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $28.9M | 1.34% | +2,007,886 | New | +$28.9M |
|
|
AVDL
20
Avadel Pharmaceuticals
AVDL
$1.43B
| $28.4M | 1.32% | 4,333,475 | – | – |
|
|
TRNX
21
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $28.2M | 1.31% | 1,458,071 -188,247 | -11% | -$3.64M |
|
22
Xoma
XOMA
$392M
| $27.4M | 1.27% | 6,096,634 +4,896,634 | +408% | +$22M |
|
23
Pacific Biosciences
PACB
$393M
| $27M | 1.25% | 4,884,368 | – | – |
|
24
AngioDynamics
ANGO
$417M
| $26.6M | 1.24% | 2,013,104 -638,362 | -24% | -$8.43M |
|
|
XNPT
25
DELISTED
XENOPORT, INC.
XNPT
| $26.2M | 1.22% | 4,605,976 +535,886 | +13% | +$3.04M |
|